Sun Pharma Advanced Research Company shareholders and shareholding pattern
NSE: SPARCBSE: 532872Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 28 Oct 2026. Previous close ₹179.24.
28 Oct: open ₹180.63, high ₹184.30, low ₹178.35
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,928 Cr778th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 3.74
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.43
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 118.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 84.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.42
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,34,66631.5% delivered
Sun Pharma Advanced Research Company's shareholding pattern for Sep 2026, filed on 9 Oct 2026, with every filing from Dec 2016: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Sun Pharma Advanced Research Company, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters65.67%
- Foreign institutions3.75%
- Indian institutions0.11%
- GovernmentsNone
- Individuals and others30.48%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Governments
- Individuals and others
| Per cent | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.93% | 66.93% | 66.93% | 66.93% | 67.47% | 67.47% | 67.47% | 68.11% | 68.11% | 68.46% | 68.46% | 68.46% | 68.46% | 68.46% | 68.46% | 68.46% | 68.46% | 68.46% | 68.46% | 68.10% | 68.10% | 69.09% | 69.09% | 69.09% | 68.22% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | |
| Indian promoters | 66.93% | 66.93% | 66.93% | 66.93% | 67.47% | 67.47% | 67.47% | 68.11% | 68.11% | 68.46% | 68.46% | 68.46% | 68.46% | 68.46% | 68.46% | 68.46% | 68.46% | 68.46% | 68.46% | 68.10% | 68.10% | 69.09% | 69.09% | 69.09% | 68.22% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 33.07% | 33.07% | 33.07% | 33.07% | 32.53% | 32.53% | 32.53% | 31.89% | 31.89% | 31.54% | 31.54% | 31.54% | 31.54% | 31.54% | 31.54% | 31.54% | 31.54% | 31.54% | 31.54% | 31.90% | 31.90% | 30.91% | 30.91% | 30.91% | 31.78% | 34.33% | 34.33% | 34.33% | 34.33% | 34.33% | 34.33% | 34.33% | 34.33% | 34.33% | 34.33% | 34.33% | 34.33% | 34.33% | 34.33% | 34.33% |
| Promoter shares pledgedShare of the promoters' own shares | 0.00% | 0.00% | 3.37% | 2.29% | 2.23% | 2.23% | 2.10% | 2.03% | 3.14% | 3.05% | 3.05% | 3.05% | 3.05% | 1.32% | 1.90% | 1.90% | 0.75% | 2.29% | 2.29% | 2.29% | 2.29% | 2.18% | 2.18% | 1.65% | 1.02% | 2.78% | 2.78% | 2.78% | 2.78% | 2.78% | 2.78% | 2.78% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Shares in issue | 24,68,95,977 | 24,68,95,977 | 24,68,95,977 | 24,68,95,991 | 25,09,36,395 | 25,09,36,395 | 25,09,36,395 | 25,59,86,900 | 25,59,86,900 | 26,20,47,506 | 26,20,47,506 | 26,20,47,506 | 26,20,47,506 | 26,20,47,506 | 26,20,47,506 | 26,20,47,506 | 26,20,47,506 | 26,20,47,506 | 26,20,47,506 | 26,34,52,000 | 26,34,52,000 | 27,18,78,966 | 27,18,78,966 | 27,18,78,966 | 27,53,29,467 | 32,45,21,588 | 32,45,21,588 | 32,45,21,588 | 32,45,21,588 | 32,45,21,588 | 32,45,21,588 | 32,45,21,588 | 32,45,21,588 | 32,45,21,588 | 32,45,21,588 | 32,45,21,588 | 32,45,21,588 | 32,45,21,588 | 32,45,21,588 | 32,45,21,588 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | – | – | 9,65,44,331 | 10,06,23,273 | 10,46,63,677 | 10,46,63,677 | 10,46,63,677 | 10,97,14,182 | 10,97,14,182 | 11,57,74,788 | 11,57,74,788 | 11,57,74,788 | 1,51,51,515 | 1,41,51,515 | 1,41,51,515 | 1,41,51,515 | 1,41,51,515 | 1,01,11,111 | 3,82,63,906 | 3,46,17,895 | 3,46,17,895 | 1,48,92,066 | 98,31,460 | 84,26,966 | 1,18,77,467 | 6,10,69,588 | 6,10,69,588 | 6,10,69,588 | 5,76,19,087 | 3,37,07,865 | 3,37,07,865 | 3,37,07,865 | 3,37,07,865 | 3,37,07,865 | 2,52,80,899 | 2,52,80,899 | 2,52,80,899 | 13,72,10,587 | 13,72,10,587 | 13,72,10,587 |
| Promoters' shares locked in | – | – | 9,65,44,331 | 9,65,43,131 | 10,05,83,535 | 10,05,83,535 | 10,05,83,535 | 10,56,34,040 | 10,56,34,040 | 11,06,94,646 | 11,06,94,646 | 11,06,94,646 | 1,41,51,515 | 1,41,51,515 | 1,41,51,515 | 1,41,51,515 | 1,41,51,515 | 1,01,11,111 | 3,82,13,906 | 3,31,63,401 | 3,31,63,401 | 1,34,87,572 | 84,26,966 | 84,26,966 | 84,26,966 | 3,37,07,865 | 3,37,07,865 | 3,37,07,865 | 3,37,07,865 | 3,37,07,865 | 3,37,07,865 | 3,37,07,865 | 3,37,07,865 | 3,37,07,865 | 2,52,80,899 | 2,52,80,899 | 2,52,80,899 | 13,72,10,587 | 13,72,10,587 | 13,72,10,587 |
Sun Pharma Advanced Research Company promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Shanghvi Finance Private Limited, 42.28%. The filing names 1 more member with no shares.Promoter buying and selling
| Holder | ||||
|---|---|---|---|---|
| Shanghvi Finance Private LimitedIndian companies, trusts and others | 42.28% | 13,72,11,787 | 13,72,10,587 | 100.00% |
| Dilip.S.ShanghviIndividuals and Hindu undivided families | 19.05% | 6,18,10,660 | 6,18,10,660 | 0.00% |
| Aditya Medisales LimitedIndian companies, trusts and others | 1.51% | 48,88,126 | 48,88,126 | 0.00% |
| Raksha Sudhir ValiaIndian companies, trusts and others | 1.28% | 41,45,231 | 41,45,231 | 0.00% |
| Sudhir Vrundavandas ValiaIndividuals and Hindu undivided families | 0.57% | 18,33,951 | 18,33,951 | 0.00% |
| Unimed Investments LimitedIndian companies, trusts and others | 0.39% | 12,67,963 | 12,67,963 | 0.00% |
| Vibha Dilip ShanghviIndividuals and Hindu undivided families | 0.33% | 10,63,236 | 10,63,236 | 0.00% |
| Vidhi Dilip ShanghviIndividuals and Hindu undivided families | 0.11% | 3,44,081 | 3,44,081 | 0.00% |
| Aalok Dilip ShanghviIndividuals and Hindu undivided families | 0.11% | 3,50,162 | 3,50,162 | 0.00% |
| Shanghvi Family & Friends Benefit TrustIndian companies, trusts and others | 0.05% | 1,54,922 | 1,54,922 | 0.00% |
| Kumud Shantilal ShanghviIndividuals and Hindu undivided families | 0.01% | 38,795 | 38,795 | 0.00% |
| Flamboyawer Finance Private LimitedIndian companies, trusts and others | 0.00% | 2,543 | 2,543 | 0.00% |
Largest public holders of Sun Pharma Advanced Research Company, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Key Employees Benefit TrustTrusts linked to the promoter group | – | 3.92% | 3.92% | 3.92% | 4.11% | 4.11% | 4.11% | 4.03% | 4.03% | 3.94% | 3.94% | 3.94% | 3.94% | 3.94% | 3.94% | 3.94% | 3.94% | 3.94% | 3.94% | 3.92% | 3.92% | 3.79% | 3.79% | 3.79% | 3.75% | 3.18% | 3.18% | 3.18% | 3.18% | 3.18% | 3.18% | 3.18% | 3.18% | 3.18% | 3.18% | 3.18% | 3.18% | 3.18% | 3.18% | 3.18% |
| Lakshdeep Investments & Finance (P) Ltd.Companies | – | 1.65% | 1.65% | 1.65% | 1.63% | 1.63% | 1.63% | 1.59% | 1.59% | 1.94% | 1.94% | 1.94% | 1.94% | 1.94% | 1.94% | 1.94% | 1.94% | 1.94% | 1.94% | 1.93% | 1.93% | 1.87% | 1.87% | 1.87% | 1.85% | 1.57% | 1.57% | 1.57% | 1.57% | 1.58% | 1.86% | 1.86% | 1.86% | 1.86% | 1.86% | 1.86% | 1.86% | 1.86% | 1.86% | 1.86% |
| Paresh Mohanlal ParekhResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.28% | 1.28% | – | 1.26% | 1.25% | 1.23% | 1.05% | 1.12% | 1.12% | 1.12% | 1.12% | 1.12% | 1.12% | 1.12% | 1.12% | 1.12% | 1.12% | 1.12% | – | 1.13% | 1.13% |
| Vijay Mohanlal ParekhResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.29% | 1.29% | – | 1.25% | 1.25% | 1.24% | 1.05% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | – | 1.13% | 1.13% |
| Enam Holdings Pvt LtdCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.04% | 1.04% | 1.04% | 1.04% | – | – | 1.04% |
| Enam Securities Private LimitedCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | – | – | – | – | 1.04% | 1.04% | – |
| Psl LimitedCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.16% | – | – |
| Rekha JhunjhunwalaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.59% | – | – | – | – | – | – | – |
| Jhunjhunwala Rekha RakeshResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.94% | 1.94% | 1.94% | 1.94% | 1.94% | 1.94% | 1.94% | – | – | – | – | – | – | – | – |
| Seafarer Overseas Growth and Income FundInstitutions Foreign Portfolio Investor | 3.06% | 3.10% | 3.25% | 3.25% | – | 3.44% | 3.40% | 3.30% | 2.78% | 1.26% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Matthews India FundInstitutions Foreign Portfolio Investor | 1.70% | 1.70% | 1.54% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Who moved in the Sep 2026 filing
Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Individuals and others: Enam Holdings Pvt Ltd newly named at 1.04%; Enam Securities Private Limited no longer named, from 1.04%